Can Sleep Apnea Lead to Decreased DLCO?
Obstructive sleep apnea (OSA) does not directly cause decreased DLCO, but the relationship is bidirectional and complex—impaired DLCO can worsen OSA-related nocturnal hypoxemia, while severe OSA with chronic hypoxemia may be associated with DLCO reduction in specific contexts.
Understanding the Relationship
The evidence shows that DLCO impairment influences OSA severity rather than OSA causing DLCO reduction in most cases. When evaluating a patient with both conditions, consider the following:
DLCO Impairment Worsens OSA-Related Hypoxemia
Patients with severe OSA (AHI ≥30 events/h) and impaired DLCO (<80% predicted) demonstrate significantly worse nocturnal oxygen desaturation compared to those with preserved DLCO 1:
- 15% higher total sleep time with SpO2 <90% (T90)
- 8.2% lower nadir SpO2
- 1.1% lower average SpO2 during sleep
This occurs because impaired gas exchange capacity compounds the oxygen desaturation that occurs during apneic events.
OSA May Affect DLCO in Specific Populations
While OSA itself doesn't typically cause DLCO reduction, there is limited evidence suggesting associations in certain contexts:
Central sleep apnea with heart failure: In patients with heart failure and central sleep apnea, reduced DLCO correlates with CSA severity 2. This reflects underlying pulmonary edema and alveolar-capillary membrane thickening from heart failure, not the sleep apnea per se.
OSA with obesity: One older reference from 1996 mentioned OSA and obesity in the context of DLCO studies 3, though this likely reflects obesity's independent effect on DLCO rather than OSA directly.
Clinical Interpretation Algorithm
When encountering decreased DLCO in a patient with suspected or confirmed OSA:
Step 1: Determine the primary pathology
- Normal spirometry + normal lung volumes + low DLCO → Consider pulmonary vascular disease, early emphysema, early ILD, or anemia 3
- Restriction + low DLCO → Suggests interstitial lung disease
- Obstruction + low DLCO → Suggests emphysema
Step 2: Assess for comorbid conditions
- Heart failure (may cause both CSA and reduced DLCO from pulmonary edema)
- Obesity (independently affects both DLCO and OSA risk)
- Pulmonary hypertension (can result from severe untreated OSA)
- Anemia (lowers DLCO and may worsen OSA-related desaturation)
Step 3: Risk stratification
- Patients with severe OSA + impaired DLCO have higher odds of hypertension (OR 1.39) and type 2 diabetes (OR 1.25) 1
- These patients require aggressive OSA treatment to prevent worsening nocturnal hypoxemia
Key Clinical Pitfalls
Don't assume OSA caused the low DLCO—search for alternative explanations including:
- Emphysema or early ILD (most common causes with normal spirometry)
- Pulmonary vascular disease
- Anemia (always check hemoglobin and adjust DLCO accordingly) 3
- Heart failure with pulmonary congestion
Don't overlook the compounding effect—when both conditions coexist, the combination creates worse nocturnal hypoxemia than either condition alone, increasing cardiovascular and metabolic risks 1.
Don't forget hemoglobin adjustment—DLCO must be corrected for hemoglobin levels, as anemia independently lowers DLCO and can worsen OSA-related desaturation 3.
Treatment Implications
For patients with both OSA and reduced DLCO:
- Prioritize OSA treatment (CPAP/APAP) to minimize nocturnal hypoxemia 4
- Treat the underlying cause of DLCO impairment (ILD, emphysema, pulmonary vascular disease, heart failure)
- Consider supplemental oxygen if nocturnal hypoxemia persists despite adequate PAP therapy
- Monitor closely for cardiovascular and metabolic complications given the elevated risk profile 1
The bottom line: OSA screening should be considered in patients with impaired DLCO to identify those at risk for severe nocturnal hypoxemia and associated complications 1, but the low DLCO itself typically reflects a separate pulmonary or systemic pathology rather than being caused by the sleep apnea.